Status:
COMPLETED
Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation
Lead Sponsor:
Innovative Medical
Conditions:
Cataract
Dry Eye
Eligibility:
All Genders
50+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the efficacy on quality of vision and dry eye signs and symptoms in patients undergoing cataract surgery using the ReZoom® multifocal IOL.
Eligibility Criteria
Inclusion
- · Males or females \> 50 years old
- Scheduled to undergo bilateral phacoemulsification with implantation of a multifocal IOL.
- Likely to complete all study visits and able to provide informed consent
- Visual potential of 20/25 or better
Exclusion
- · Prior use of topical cyclosporine
- Known contraindications to any study medication or ingredients
- Active ocular diseases or uncontrolled systemic disease
- Active ocular allergies
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00349583
Last Update
June 1 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmic Consultants of Long Island
Rockville Centre, New York, United States, 11570